Trials / Completed
CompletedNCT02270268
Effects of Pectin Supplementation in Diarrhea-predominant Irritable Bowel Syndrome
Therapeutic Effects of Pectin Supplementation in Patients With Diarrhea-predominant Irritable Bowel Syndrome
- Status
- Completed
- Phase
- Phase 3
- Study type
- Interventional
- Enrollment
- 114 (actual)
- Sponsor
- Nanjing PLA General Hospital · Academic / Other
- Sex
- All
- Age
- 18 Years – 70 Years
- Healthy volunteers
- Not accepted
Summary
The purpose of this study is to investigate the effect of pectin, a kind of soluble dietary fiber, on clinical symptoms, gut microbiota and the immune status in patients with diarrhea-predominant irritable bowel syndrome
Detailed description
Patients were randomized to receive either pectin or placebo. Treatment consisted of 6 weeks supplementation with pectin (fiber group) or placebo (maltodextrin). We evaluated the clinical symptoms, gut microbiota and the immune markers in two groups.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DIETARY_SUPPLEMENT | Pectin | Pectin （Andeli Ltd. Yantai, China）, 24g/d for six weeks |
| DIETARY_SUPPLEMENT | maltodextrin |
Timeline
- Start date
- 2011-11-01
- Primary completion
- 2013-10-01
- Completion
- 2013-10-01
- First posted
- 2014-10-21
- Last updated
- 2016-03-24
Source: ClinicalTrials.gov record NCT02270268. Inclusion in this directory is not an endorsement.